Pharmaceutical News and Articles

FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease

Job Strain Tied to New Sleep Disturbances Over Time

U.S. workers who report high job strain experience significantly more sleep disturbances over time, according to a study published online Jan. 8 in the American

FDA Proposes Nicotine Limits on Combustible Tobacco Products

The U.S. Food and Drug Administration has issued a proposed rule to lower the level of nicotine in cigarettes and certain other combustible tobacco products in

TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the addition of lenvatinib and pembrolizumab

Cancer Mortality Continued to Decline Through 2022

Cancer mortality is continuing to decline, but the incidence of certain cancer types is increasing, especially among women, according to the Cancer Statistics,

Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer

For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab emtansine (T-DM1) improves overall survival

Teen Stress Is Expensive, Experts Say -- So How Can We Reduce It?

Stressed-out teenagers appear to be dragging down the U.S. economy, a new study says. Teenagers suffering from anxiety or depression are less likely to enter th

Sex Disparities Identified in Natural History of Tourette Syndrome

Females with Tourette syndrome (TS) are less likely than males to be formally diagnosed, with symptom onset and diagnosis occurring at a later age for females,

Higher Intake of Red Meat Linked to Increased Risk for Dementia

Higher intake of red meat, especially processed red meat, is associated with an increased risk for developing dementia and subjective cognitive decline (SCD), a

Zoledronate Prevents Morphometric Vertebral Fractures Over 10 Years

For early postmenopausal women, zoledronate administered at baseline and five years is effective for preventing morphometric vertebral fracture, according to a